Providing insights for better decision-making to improve the treatment of patients in Europe
ARWEN is the Actionable Real World Evidence Network, created by LOGEX to unlock the value of real-world data by connecting forward-thinking hospitals and clinicians and enabling benchmarking, collaboration, and simplifying the sharing of treatment insights across different healthcare systems.
Join Once, Benefit Continuously
ARWEN is a quickly expanding pan-European network for forward-thinking hospitals, healthcare professionals and clinicians who believe in making data-driven and evidence-based decisions when caring for patients.
Latest updates
We have the answer to your questions
Actionable Real World Evidence Network
A platform that helps hospitals generate, share and use treatment insights to achieve better patient care.
We help hospitals by giving insights into the daily practice using data analysis, enabling them to benchmark their clinical practice against others, allowing clinicians to learn from others by getting a view outside their hospital walls and empowering hospitals to identify improvement potential in the treatments they offer.
A standardised,
fit-for-purpose platform
We offer a platform to connect supply and demand of drug-related research questions on our network.
WITH BEST-IN-CLASS
DATA ANALYSIS SUPPORT
We simplify data extraction and validation, so hospitals can focus on caring for patients.
Unlocking the value of real-world data
We enable the use of real-world data that reflects the actual population treated to pinpoint improvement potential and best practices.
Enabling meaningful collaboration
We enable regulatory parties, insurance companies, life science companies, hospitals, and clinicians to collaborate on real-world evidence projects to improve care.
ARWEN ensures continuous control of your data
Your data is yours
You are not our product, and neither is your data. We are data analysts, not data brokers.
Your data is safe
The privacy and security of your data always come first. We hold ourselves to the same standards as you do.
Your data is valuable
How you unlock the value in your data, is your choice. We work to turn data into value, in full transparency.
Your data is vital
Your data holds the potential to fast-track vital real-world evidence. We are proud to be a highly respected and trusted 3rd party.
Our solutions
Drug use &
epidemiology analysis
Main Qs answered
How many and what types of patients are using a drug? How many are eligible?
Examples of typical projects
- Epidemiology study
- Patient group analysis and segmentation
- (Medicine) treatment pattern analysis
Standard of care &
patient pathway analysis
Main Qs answered
How are patients treated in the hospitals? What are key improvement areas?
Examples of typical projects
- Analysis of patient pathways
- Treatment adherence to guidelines
- Segmentation of patient groups by treatment modality
- Identification of improvement areas
Drug impact analysis on outcomes & costs
Main Qs answered
What is / will be the impact of a drug on the hospital (pathway, costs, outcomes, etc.)?
Examples of typical projects
- Impact of drugs on hospital costs, efficiency and patient outcomes
- Horizon scanning (analysis of impact of upcoming drugs)
- Drug effectiveness comparison
Frequently asked questions
ARWEN makes your real-world data (RWD) more actionable: generating insights in a way that s fast, scalable and transparent. With ARWEN collecting, standardising and analysing RWD for treatment improvement projects is no longer a struggle.
Actionable means you can act upon the insights we provide. They answer your questions about how to improve the care of your patients.
There is no investment needed from the hospitals. Hospitals can join for free and benefit continuously.
ARWEN allows hospitals to get answers to their own specific questions in the treatment improvement projects they participate in. This helps hospitals to identify improvement potential in their care to patients. Besides that, hospitals and clinicians can compare their own care to that of a benchmark. On top of that, ARWEN members get access to regular useful insight reports and international best practices that can help them improve the care they provide to patients.
No. ARWEN was founded by LOGEX after seeing the barriers that hold many healthcare providers back when trying to apply RWE to improve care. LOGEX believes it can help remove these barriers whilst remaining a trusted and impartial third party. That is why it chose to fund the start-up of ARWEN entirely independently.
The hospital is always the data controller, in compliance with GDPR terms. ARWEN ensures continuous control of hospitals on your data:
- Your data is yours – ARWEN is not a data broker
- Your data is safe – The privacy and security of your data always comes first
- Your data is valuable – ARWEN provides clear and transparent financial benefits
- Your data is vital – We are proud to support your ambition to help fast-track crucial research
Patient-level data will not be shared. We are GDPR compliant, so only with the explicit permission of the hospital aggregated anonymised data can be shared. For most projects, only population level data is required. For sharing aggregated anonymised data at the hospital level, additional permission is always needed.
ARWEN is powered by LOGEX. An industry-leading healthcare analytics company. LOGEX deploys data security and privacy by design. Our dedicated information security office monitors security procedures in-depth, assuring your data is safe and secure. In addition, we support multiple user authorisation levels to control the privacy and transparency of your data.
We are fully GDPR compliant and ISO27001 certified.
ARWEN does not sell anonymised data. ARWEN ensures continuous control of your data. ARWEN is not a data broker.
The Data Processing Agreement (DPA) specifies the data retention period.
To obtain a longitudinal view of patients, we require at least three years of routine healthcare data- collected in all hospitals. This includes prescription data, medical procedures, and diagnosis codes (usually expressed as ICD10-codes).
Complex RWE treatment improvement projects
ARWEN aims to enable complex RWE treatment improvement projects and programmes. Additional data sources such as pathology, laboratory, imaging, and clinical outcomes are collected and linked to fully understand patient treatment and outcomes.
At LOGEX, we have worked for hospitals since 2008. In the past years, we have supported the extraction and analytics of RWD in local and international initiatives. For example, standards of care, the impact of COVID, patient pathway optimisation. We believe that collecting, standardising and analysing data to participate in more RWE treatment improvement projects should not have to be a struggle; that is why we have founded ARWEN.
Leading experts about the importance of RWE and ARWEN
“
The potential grows with participation – RWE is the difference our future needs!
Timo Schöpke, MD, MBA, Director of Emergency Department, Klinikum Barnim, Germany
“
Real World Data can provide solid evidence, underpinning plans to improving patient care
Julian Given, Planning and Performance Business Manager at Gateshead Health NHS Foundation Trust
“
Translating (OR Transcribing) real world clinical data into systematic evidence for improving health care
Konstantinos Chiotis, Neurology resident and postdoctoral fellow, Karolinska Institutet
“
We need a way to track the uptake of new therapies in our hospital. ARWEN is a way to do that
Doug Robertson, Associate Medical Director at Mid Cheshire Hospitals Foundation Trust
